Teng R - Search Results

1

Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.

Teng R, Harris SC, Nix DE, Schentag JJ, Foulds G, Liston TE. Teng R, et al. J Antimicrob Chemother. 1995 Aug;36(2):385-94. doi: 10.1093/jac/36.2.385. J Antimicrob Chemother. 1995. PMID: 8522468 Clinical Trial.

2

Determination of trovafloxacin, a new quinolone antibiotic, in biological samples by reversed-phase high-performance liquid chromatography.

Teng R, Tensfeldt TG, Liston TE, Foulds G. Teng R, et al. J Chromatogr B Biomed Appl. 1996 Jan 12;675(1):53-9. doi: 10.1016/0378-4347(95)00340-1. J Chromatogr B Biomed Appl. 1996. PMID: 8634768

3

Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers.

Teng R, Liston TE, Harris SC. Teng R, et al. J Antimicrob Chemother. 1996 May;37(5):955-63. doi: 10.1093/jac/37.5.955. J Antimicrob Chemother. 1996. PMID: 8737145 Clinical Trial.

4

The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension.

Foulds G, Luke DR, Teng R, Willavize SA, Friedman H, Curatolo WJ. Foulds G, et al. Among authors: teng r. J Antimicrob Chemother. 1996 Jun;37 Suppl C:37-44. doi: 10.1093/jac/37.suppl_c.37. J Antimicrob Chemother. 1996. PMID: 8818844 Clinical Trial.

5

Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.

Teng R, Girard D, Gootz TD, Foulds G, Liston TE. Teng R, et al. Antimicrob Agents Chemother. 1996 Mar;40(3):561-6. doi: 10.1128/AAC.40.3.561. Antimicrob Agents Chemother. 1996. PMID: 8851571 Free PMC article.

6

Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.

Vincent J, Venitz J, Teng R, Baris BA, Willavize SA, Polzer RJ, Friedman HL. Vincent J, et al. Among authors: teng r. J Antimicrob Chemother. 1997 Jun;39 Suppl B:75-80. doi: 10.1093/jac/39.suppl_2.75. J Antimicrob Chemother. 1997. PMID: 9222074 Clinical Trial.

7

Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers.

Vincent J, Teng R, Dogolo LC, Willavize SA, Friedman HL. Vincent J, et al. Among authors: teng r. J Antimicrob Chemother. 1997 Jun;39 Suppl B:81-6. doi: 10.1093/jac/39.suppl_2.81. J Antimicrob Chemother. 1997. PMID: 9222075 Clinical Trial.

8

Oral bioavailability of trovafloxacin with and without food in healthy volunteers.

Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J. Teng R, et al. J Antimicrob Chemother. 1997 Jun;39 Suppl B:87-92. doi: 10.1093/jac/39.suppl_2.87. J Antimicrob Chemother. 1997. PMID: 9222076 Clinical Trial.

9

Effect of Maalox and omeprazole on the bioavailability of trovafloxacin.

Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J. Teng R, et al. J Antimicrob Chemother. 1997 Jun;39 Suppl B:93-7. doi: 10.1093/jac/39.suppl_2.93. J Antimicrob Chemother. 1997. PMID: 9222077 Clinical Trial.

10

Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans.

Vincent J, Dogolo L, Baris BA, Willavize SA, Teng R. Vincent J, et al. Among authors: teng r. Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):427-30. doi: 10.1007/BF01691577. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9758287 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters